期刊名称:JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
 |
The Journal of Steroid Biochemistry and Molecular Biology is devoted to new experimental or theoretical developments in areas related to steroids. It publishes original papers as well as general and mini-reviews, proceedings of selected meetings and rapid communications (brief highly-topical articles of particular interest). The journal covers a wide range of topics relating to steroids:- *Molecular, cellular, and physiological actions of steroid hormones, steroid anti-hormones and their analogs via regulation of gene expression or other mechanisms. *Structure, function, regulation, and cell biology of receptors of the steroid-thyroid-retinoid superfamily. *Cross-talk between steroids, steroid receptors and other signal transduction pathways. *Steroids and cell proliferation, regulation of cell cycle genes. *Steroid transport. *Steroids and cancer: functional relationships in normal and neoplastic tissues between steroid hormones and cytokines, growth factors, growth inhibitors, and oncogenes. *Steroids and cancer prevention. *Biosynthesis, secretion, and metabolism of steroids and of biologically-related compounds, and their regulation by peptide hormones, prostaglandins and other substances. *Molecular aspects of enzymes involved in steroidogenesis. *Novel therapeutic applications of new steroid agonists or antagonists. *Steroids and neuroendocrinology or neuroimmunology. Neurosteroids, steroid action on synactic transmission and modulation. *Steroid hormones and hypertension. *Steroids and their actions on bone and on the cardiovascular systems. *Steroid enzyme inhibitors. *Steroids and analogs in menopause. *Steroids in hormone replacement therapy. *Steroid hormones in osteoporosis: basic and clinical applications. *Steroids and contraception. *Defects in steroid metabolism. *Steroid hormones during pregnancy, development and sex differentiation. *Structure, physicochemical, chemical and pharmacological characteristics of natural and synthetic steroids and related compounds of biological interest. *Innovative techniques relating to steroids and biologically-related substances. *Clinical and physiological studies of inborn or acquired changes of biosynthesis, metabolism or action of steroids and their receptors. *Comparative endocrinology and evolution of steroids. *Environmental effects on steroid metabolism and action. |
Instructions to Authors
Authors are requested to submit their original manuscript and figures with three copies to:Editor-in-Chief, J. R. Pasqualini, Steroid Hormone Research Unit, Institut de Puericulture, 26 Boulevard Brune, 75014 Paris, France. Tel:(+33) 1 4542 4121, Fax: (+33) 1 4542 6121, E-mail: jorge.pasqualini@wanadoo.fr
Manuscripts must be in English.
Submission of a paper implies that it has not been published previously, that it is not under consideration for publication elsewhere, and that if accepted it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the publisher.
Authors are invited to suggest the names of 4-6 potential referees specializing in the subject of their paper and should provide their full names and addresses, as well as fax and telephone numbers.
Manuscript Preparation
General: Manuscripts must be typewritten, double-spaced with wide margins on one side of white paper. Good quality printouts with a font size of 12 or 10 pt are required. The corresponding author should be identified (include a Fax number and E-mail address). Full postal addresses must be given for all co-authors. Number all pages consecutively. Authors should consult a recent issue of the journal for style if possible. An electronic copy of the paper should accompany the final version. The Editor reserves the right to adjust style to certain standards of uniformity. Authors should retain a copy of their manuscript since we cannot accept responsibility for damage or loss of papers. Original manuscripts are discarded one month after publication unless the Publisher is asked to return original material after use.
Paper length: Manuscripts should not exceed 20 typewritten pages, rapid communications should not exceed three pages, preliminary notes three pages and general reviews about 30 pages.
Abstract: A summary of up to 200 words must be supplied.
Text: Follow this order when typing manuscripts: Cover page (Title, Authors, Affiliations), Abstract, Keywords, Main text (Introduction, Materials and Methods, Results, Discussion including Conclusion), Acknowledgements, Appendix, References, Vitae, Figure Captions and then Tables. Do not import the Figures or Tables into your text. Rapid communications should follow the same sequence set out above for regular papers. For review articles the choice of headings is left to the author. The corresponding author should be identified with an asterisk and footnote. All other footnotes (except for table footnotes) should be identified with superscript Arabic numbers.
Nomenclature: Should be as recommended in the IUPAC/IUB 1967 revised rules for the nomenclature of steroids which have been published in J. Steroid Biochem. 1 (1970) 143. SI symbols for units should be used [Systeme International d'Unites; see Symbols, Signs and Abbreviations, Recommended for British Scientific Publications (1969) The Royal Society, London].
References: All publications cited in the text should be presented in a list of references following the text of the manuscript. In the text refer to references by a number in square brackets on the line (e.g. Since Ojasoo and Dore [1]), and the full reference should be given in a numerical list at the end of the paper. References should be given in the following form:
1. T. Ojasoo, J.-C. Dore, Taxonomy of nuclear receptors and SERPINS by multivariate analysis of amino-acid composition, J. Steroid Biochem. Mol. Biol. 58 (2) (1996) 167-181.
2. E.S. Kawasaki, A.M. Wang, Detection of gene expression, in: H.A. Erlich (Ed.), PCR Technology, Stockton Press, New York, 1989, pp. 89-97.
Illustrations: All illustrations should be provided in camera-ready form, suitable for reproduction (which may include reduction) without retouching. Photographs, charts and diagrams are all to be referred to as "Figure(s)" and should be numbered consecutively in the order to which they are referred. They should accompany the manuscript, but should not be included within the text. All illustrations should be clearly marked on the back with the figure number and the author's name. All figures are to have a caption. Captions should be supplied on a separate sheet. Line drawings: Good quality printouts on white paper produced in black ink are required. All lettering, graph lines and points on graphs should be sufficiently large and bold to permit reproduction when the diagram has been reduced to a size suitable for inclusion in the journal. Dye-line prints or photocopies are not suitable for reproduction. Do not use any type of shading on computer-generated illustrations. Photographs: Original photographs must be supplied as they are to be reproduced (e.g. black and white or colour). If necessary, a scale should be marked on the photograph. Please note that photocopies of photographs are not acceptable. Colour: Where colour figures are required, the author will be charged accordingly (further details of costs are available from Author Services, at Elsevier Science).
Tables: Tables should be numbered consecutively and given a suitable caption and each table typed on a separate sheet. Footnotes to tables should be typed below the table and should be referred to by superscript lowercase letters. No vertical rules should be used. Tables should not duplicate results presented elsewhere in the manuscript, (e.g. in graphs).
Instructions regarding GenBank/DNA Sequence Linking:
DNA sequences and GenBank Accesion numbers: Many Elsevier journals cite "gene accession numbers" in their running text and footnotes. Gene accession numbers refer to genes or DNA sequences about which further information can be found in the database at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine. Elsevier authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources, should type this information in the following manner: For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalised. (See Example 1 below). This combination of letters and format will enable Elsevier's typesetters to recognize the relevant texts as accession numbers and add the required link to GenBank's sequences.
Example 1: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link. In the final version of the printed article, the accession number text will not appear bold or underlined (see Example 2 below).
Example 2: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228, a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases enabling readers to go directly to that source from the article.
Electronic Submission
Authors should submit an electronic copy of their paper with the final version of the manuscript. The electronic copy should match the hardcopy exactly. Always keep a backup copy of the electronic file for reference and safety. Full details of electronic submission and formats can be obtained from http://www.elsevier.nl/locate/disksub or from Author Services at Elsevier Science.
Proofs
Proofs will be sent to the author (first named author if no corresponding author is identified on multi-authored papers) by PDF wherever possible and should be returned within 48 hours of receipt, preferably by e-mail. Corrections should be restricted to typesetting errors; any other amendments made may be charged to the author. Any queries should be answered in full. Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections are returned to us in one all-inclusive e-mail or fax. Subsequent additional corrections will not be possible, so please ensure that your first communication is complete. Should you choose to mail your corrections, please return them to: Log-in Department, Elsevier Science, Stover Court, Bampfylde Street, Exeter, Devon EX1 2AH, UK.
Offprints
Twenty five offprints will be supplied free of charge. Additional offprints and copies of the issue can be ordered at a specially reduced rate using the order form sent to the corresponding author after the manuscript has been accepted. Orders for reprints (produced after publication of an article) will incur a 50% surcharge.
Copyright
All authors must sign the "Transfer of Copyright" agreement before the article can be published. This transfer agreement enables Elsevier Science Ltd to protect the copyrighted material for the authors, without the author relinquishing his/her proprietary rights. The copyright transfer covers the exclusive rights to reproduce and distribute the article, including reprints, photographic reproductions, microfilm or any other reproductions of a similar nature, and translations. It also includes the right to adapt the article for use in conjunction with computer systems and programs, including reproduction or publication in machine-readable form and incorporation in retrieval systems. Authors are responsible for obtaining from the copyright holder permission to reproduce any material for which copyright already exists.
Author Services
For queries relating to the general submission of manuscripts (including electronic text and artwork) and the status of accepted manuscripts, please contact Author Services, Log-in Department, Elsevier Science, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK. E-mail: authors@elsevier.co.uk, Fax: +44 (0) 1865 843905, Tel: +44 (0) 1865 843900. Authors can also keep a track of the progress of their accepted article through our OASIS system on the Internet. For information on an article go to the Internet page: http://www.elsevier.nl/oasis and key in the corresponding author's name and the Elsevier reference number.
Editorial Board
- Editor-in-Chief:
- J.R. Pasqualini, Institut de Puériculture, 26 Boulevard Brune, 75014 Paris, France. Tel.: +33-1-45399109; Tel: (+33) 1 4542 4121, Fax: (+33) 1 4542 6121, Email: jorge.pasqualini@wanadoo.fr
- Honorary Editor-in-Chief:
- R. Scholler, Institut de Puériculture, 26 Boulevard Brune, 75014 Paris, France
- Honorary Associate Editors:
- H. Adlercreutz, Helsinki, Finland
E.V. Jensen, Huddinge, Sweden R.J.B. King, Guildford, UK
- Corresponding Editors:
- J.D. Baxter, San Francisco, CA, USA
M. Beato, Marburg/Lahn, Germany A.S. Bhatnagar, Basel, Switzerland R. Bouillon, Leuven, Belgium A. Brodie, Baltimore, MD, USA K.J. Catt, Bethesda, MD, USA S. Chen, Duarte, CA, USA G. Chetrite, Paris, France J.A. Cidlowski, Research Triangle Park, NC, USA R. Clarke, Washington, DC, USA P.D. Darbre, Reading, UK G. Daxenbichler, Innsbruck, Austria E.R. de Kloet, Leiden, The Netherlands A.F. De Nicola, Buenos Aires, Argentina E.R. DeSombre, Chicago, IL, USA B.N. Diaz-Chico, Las Palmas, Spain R.B. Dickson, Washington, DC, USA M. Dowsett, London, UK M.L. Dufau, Bethesda, MD, USA D.P. Edwards, Denver, CO, USA H.A. Eriksson, Stockholm, Sweden J.W. Funder, Clayton, Australia S.A. Fuqua, Houston, TX, USA G. Greene, Chicago, IL, USA B. Groner, Frankfurt am Main, Germany J.-?Gustafsson, Huddinge, Sweden K.B. Horwitz, Denver, CO, USA I. Huhtaniemi, Turku, Finland V.C. Jordan, Chicago, IL, USA J. Kato, Tokyo, Japan B.S. Katzenellenbogen, Urbana, USA A.M. Kaye, Rehovot, Israel J. Kitawaki, Kyoto, Japan H.J. Kloosterboer, Oss, The Netherlands F. Labrie, Ste-Foy, Canada S. Liao, Chicago, IL, USA V.B. Mahesh, Augusta, GA, USA L. Martini, Milan, Italy B.S. McEwen, New York, NY, USA H. Michna, München, Germany E. Milgrom, Le Kremlin-Bicêtre, France L.J. Murphy, Winnipeg, Canada M.I. New, New York, NY, USA A.W. Norman, Riverside, USA B.W. O'Malley, Houston, TX, USA J. Paris, Monaco M.G. Parker, London, UK G. Pérez-Palacios, Mexico City, Mexico J.P. Raynaud, Paris, France R. Renkawitz, Giessen, Germany H. Rochefort, Montpellier, France J. Russo, Philadelphia, PA, USA E.R. Sanchez, Toledo, OH, USA H. Sasano, Sendai, Japan B. Sato, Osaka, Japan M. Serio, Florence, Italy E.R. Simpson, Clayton, Australia C. Sonnenschein, Boston, MA, USA L. Stárka, Prague, Czech Republic R.L. Sutherland, Darlinghurst, Australia J.H.H. Thijssen, Utrecht, The Netherlands D.O. Toft, Rochester, MN, USA P. Tuohimaa, Tampere, Finland P. Vihko, Oulu, Finland G. Vollmer, Dresden, Germany C.R. Wira, Hanover, USA G. Verhoeven, Leuven, Belgium
|